FTX-6058
Modify Date: 2024-04-11 12:28:48
FTX-6058 structure
|
Common Name | FTX-6058 | ||
|---|---|---|---|---|
| CAS Number | 2490676-18-9 | Molecular Weight | 403.41 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H18FN5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of FTX-6058FTX-6058 is a potent and orally active inhibitor of Embryonic Ectoderm Development (EED). FTX-6058 can induce HbF protein expression in cell and murine models. FTX-6058 can be used for the research of select hemoglobinopathies, including sickle cell disease and β-thalassemia[1][2]. |
| Name | FTX-6058 |
|---|
| Description | FTX-6058 is a potent and orally active inhibitor of Embryonic Ectoderm Development (EED). FTX-6058 can induce HbF protein expression in cell and murine models. FTX-6058 can be used for the research of select hemoglobinopathies, including sickle cell disease and β-thalassemia[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | FTX-6058 inhibits PRC2 via binding to EED, which induces robust HbF protein expression in both cell and murine models[2]. |
| References |
[1]. Boerner LK. Virtual meeting delivers first time drug structures. April 12, 2021. |
| Molecular Formula | C22H18FN5O2 |
|---|---|
| Molecular Weight | 403.41 |